- Home
- TLRY vs GAIN Comparison
TLRY vs GAIN Comparison
Compare TLRY & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | GAIN |
|---|---|---|
| Founded | N/A | 2005 |
| Country | Canada | United States |
| Employees | N/A | 70 |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.4M | 653.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | GAIN |
|---|---|---|
| Price | $3.91 | $15.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $72.33 | $14.75 |
| AVG Volume (30 Days) | ★ 3.5M | 184.4K |
| Earning Date | 04-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 9.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | $9.07 |
| Revenue Next Year | $19.98 | $7.32 |
| P/E Ratio | ★ N/A | $4.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $13.14 |
| 52 Week High | $15.70 | $17.14 |
Technical Indicators
Market Signals| Indicator | TLRY | GAIN |
|---|---|---|
| Relative Strength Index (RSI) | 22.50 | 46.38 |
| Support Level | $0.77 | $15.78 |
| Resistance Level | $4.85 | $17.00 |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 3.18 | 20.21 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.